Connect to other sites within the UBM Medica Network
Health Care Utilization High Among Older Adults With AML
Older adults with acute myeloid leukemia have a substantial health care burden and high rates of health care utilization even at the end of life.
International Experts Propose New Pediatric NHL Staging System
A revised International Pediatric Non-Hodgkin Lymphoma Staging System (IPNHLSS) could allow for more precise staging for children and adolescents with NHL.
Top 5 Reasons to Participate in Advocacy in Washington, DC
Advocacy is about making sure that our lawmakers enact the best healthcare policies for our patients. Just as we have a duty to our patients in the clinic, we also have a duty to advocate for laws that benefit patients’ health.
Trabectedin Fails to Improve PFS in Soft-Tissue Sarcoma
Trabectedin failed to improve progression-free survival outcomes compared to doxorubicin as first-line therapy for advanced/metastatic soft-tissue sarcoma.
Lenvatinib Offers Promising Response Rate in Thyroid Cancer
The multi-targeted TKI lenvatinib showed promise in a phase II trial of patients with advanced, radioiodine-refractory, differentiated thyroid cancer.
Metformin May Not Improve Pancreatic Cancer Survival
Metformin, a common drug for type II diabetes, did not improve the survival of patients with pancreatic ductal adenocarcinoma.
Top Highlights From the 2015 AACR Annual Meeting
This slide show features some of the top highlights from the 2015 American Association for Cancer Research (AACR) Annual Meeting.
Neutropenia and Abdominal Pain in a 30-Year-Old Patient
A 30-year-old man who recently underwent induction chemotherapy for bone marrow transplant is admitted with neutropenia and right lower-quadrant abdominal pain. What is your diagnosis?
Managing Treatment-Related Neurotoxicity
Understanding treatment-induced neurotoxicity can be difficult when treating patients with central nervous system (CNS) malignancies.
Benefits of Multi-Gene Panel Testing for Breast Cancer Risk
A multi-gene panel test provides better diagnostic yield compared with a limited BRCA1/2 genetic test for patients at risk for hereditary breast cancer.
By clicking Accept, you agree to become a member of the UBM Medica Community.